Recent developments in CD19-targeted therapies for follicular lymphoma.
Aditi SahaJulio C ChavezPublished in: Expert opinion on biological therapy (2024)
CD19 is an attractive target for therapeutic development in follicular lymphoma. Given its effectiveness, it will continue to move forward as a promising therapy for this disease.